TO ASSESS EFFICACY OF DAPAGLIFLOZIN IN PATIENTS WITH CIRRHOSIS WITH DIABETES AS COMPARED TO STANDARD MEDICAL REGIME
Not Applicable
- Conditions
- Health Condition 1: K742- Hepatic fibrosis with hepatic sclerosis
- Registration Number
- CTRI/2023/06/054459
- Lead Sponsor
- Pt BD Sharma Institute of Medical Science, Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All Patients with liver cirrhosis having age 18years to 70years with Diabetes Mellitus requiring drug treatment. Patients who are willing to participate
Exclusion Criteria
Age <18years or >70years. Cerebrovascular disorder, any neurological disorder including dementia/Alzheimerâ??s etc.Pregnancy.Chronic kidney disease . Any malignancy excluding Hepatocellular Carcinoma .Patient who refused to give consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method